Psychopharmacology and Psychiatry Updates
Un pódcast de Psychopharmacology Institute
Categorías:
213 Episodo
-
Acute Agitation and Dexmedetomidine: A Novel Treatment Approach
Publicado: 30/8/2023 -
The Prevalence and Risks of RBD
Publicado: 25/8/2023 -
ADHD Medication and Their Role in Anxiety and Depression
Publicado: 20/8/2023 -
In the Realm of Sleep: RBD Diagnosis Explained
Publicado: 15/8/2023 -
NAC in Schizophrenia: Pie in the Sky or Groundbreaking Solution?
Publicado: 10/8/2023 -
Child Psychiatry: NAC and SAMe
Publicado: 5/8/2023 -
Youth Psychotropic Prescription Trends: Pandemic Influence
Publicado: 31/7/2023 -
Nature's Remedies in Youth: St. John's Wort and Valerian
Publicado: 26/7/2023 -
Exploring Serotonergic Antidepressants for PMDD
Publicado: 21/7/2023 -
Exploring Omega-3's Role in Child Psychiatry
Publicado: 16/7/2023 -
ADHD Meds for Preschoolers: Lisdexamfetamine
Publicado: 11/7/2023 -
Using Ginkgo Biloba in Children
Publicado: 6/7/2023 -
Examining COVID's Lasting Effects in Psychiatry
Publicado: 1/7/2023 -
Beyond SSRIs: Antipsychotic Augmentation in OCD
Publicado: 26/6/2023 -
Overcoming Barriers to Metabolic Monitoring in Youth Treated With SGAs
Publicado: 21/6/2023 -
Exploring Outcomes and Strategies in OCD Treatment After the First Trial
Publicado: 16/6/2023 -
Diving Into the APA Annual Meeting: Highlights and Insights!
Publicado: 11/6/2023 -
Exploring the Intriguing World of Microdosing Psilocybin
Publicado: 6/6/2023 -
SSRIs for OCD: A Closer Look at First-Line Treatment
Publicado: 1/6/2023 -
Exploring Nonstimulant Treatments for ADHD
Publicado: 27/5/2023
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.